Meanwhile, IGF2BP1 could increase the stability of heart development protein with EGF-like domains 1 (HEG1) mRNA in an m6A-dependent way, which subsequently increases liver cancer cell resistance to oxaliplatin.51 The gene discussed is IGF2BP1; the disease is liver cancer.